More results...

logo_oncodesign_services_blanc_couleurs

More results...

Contact
  • Discovery Services
    • Structural Biology
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • Bioanalysis, Formulation, Immunogenicity and Biomarkers
    • Bioconjugation and Radiochemistry Platform
    • In Vivo Pharmacology
    • In Vivo Imaging
  • Oncology
    • Immuno-Oncology
    • Tumor Models
    • Orthotopic Models
    • Metastatic Models
    • Humanized Models
    • Radiopharmaceutical Development
  • Inflammation
    • Autoimmunity Models
    • Dermal Models
    • Endometriosis Models
    • IBD Models
    • Kidney Models
    • Liver Models
    • Lung Models
    • Systemic Inflammation Models
  • Microbiome
  • Resources
  • Join us!
    • Job offers
    • Our HR Policy
  • About us
    • Our history
    • Management
    • Our CSR approach
    • Network
    • News
Contact
  • EXPLORE: Identification and validation of therapeutic targets
  • DRIVE-IDDS: integrated drug discovery solution
  • INPACT: integrated services in preclinical pharmacology
  • SOLO: offers from our innovative technical platforms
  • D-VLOP: bringing your drug to IND filing
Home . Oncodesign announces the third extension of a research contract with Isarna Therapeutics . Page 11

News

Ressources presse
21/06/2016

[FR] Les Echos – Une année 2015 d’excellente facture

Read more
Ressources presse
05/06/2016

[FR] La Tribune – Oncodesign à la pointe de l’innovation pour guérir le cancer

Read more
Financial Press Release | Oncodesign
Press release
30/05/2016

Oncodesign is granted new patent protecting key molecules generated from its Nanocyclix technology platform for next generation kinase inhibitors

Read more
Financial Press Release | Oncodesign
Press release
03/05/2016

Oncodesign and Ipsen enter into a strategic partnership in oncology and Oncodesign joins Ipsen’s Paris-Saclay Campus

Read more
Ressources presse
03/05/2016

[FR] Les Echos – Oncodesign et Ipsen s’allient dans un partenariat stratégique en oncologie

Read more
Financial Press Release | Oncodesign
Press release
05/01/2016

Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration

Read more
Financial Press Release | Oncodesign
Press release
17/12/2015

Preclinical validation of Oncodesign’s first radiotracer prior to human application

Read more
Ressources presse
25/11/2015

[FR] Retrouvez l’interview de Philippe Genne lors du Salon Actionaria 2015

Read more
Financial Press Release | Oncodesign
Press release
21/10/2015

Oncodesign presents novel LRRK2 inhibitor jointly discovered with Ipsen at the 2015 Neurosciences meeting in Chicago

Read more
Financial Press Release | Oncodesign
Press release
16/10/2015

Oncodesign pursues its strategy of expansion in North America

Read more
Ressources presse
16/10/2015

[FR] Les Echos – Oncodesign crée un site de recherche avec Mispro à Montréal

Read more
Financial Press Release | Oncodesign
Press release
16/07/2015

Oncodesign announces the creation of its Scientific Advisory Board

Read more
1 2 … 10 11 12 13 14

Contact-us

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Get in touch

Science within easy reach!

Receive our general news!

Explore Oncodesign Services vitality
logo_oncodesign_services_blanc_couleurs

Follow us

linkedin twitter Stand with Ukraine
  • Discovery Services
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • In Vivo Pharmacology
  • Therapeutic areas
    • Oncology
    • Inflammation
  • Integrated Solutions
    • Small Molecule
    • Molecular Radiotherapy
    • Biologics
  • Legal notice
  • Personal data policy
  • General Terms And Conditions Of Purchase
  • Contact